NCT00428766View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Epithelial Ovarian Cancer

Interventions

DRUG

MORAb-003

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Morphotek

INDUSTRY